found that exosomal mRNA‐based (CUL9, KMT2D, PBRM1, PREX2, and SETD2) signatures may serve as tools for the early detection of ccRCC and differential diagnoses of uncertain renal masses.23 Here, SETD2 is linked to nonpapillary renal cell carcinoma.